Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
PENETHAMATE HYDRIODIDE (PENETHAMATE), BENETHAMINE PENICILLIN (PENICILLIN), FRAMYCETIN SULFATE (FRAMYCETIN)
Boehringer Ingelheim Vetmedica GmbH
QJ51RC25
PENETHAMATE HYDRIODIDE (PENETHAMATE), BENETHAMINE PENICILLIN (PENICILLIN), FRAMYCETIN SULFATE (FRAMYCETIN)
Unknown
intramammary Suspension
POM
Bovine
Penethamate hydroiodide, combinations with other antibacterials
Antibacterial
Authorised
2012-11-23
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ubrostar Dry Cow 100 mg / 280 mg / 100 mg Intramammary Suspension for cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 4.5 g intramammary syringe contains: ACTIVE SUBSTANCES: Penethamate Hydriodide 100 mg (equivalent to 77.2 mg penethamate) Benethamine Penicillin 280 mg (equivalent to 171.6 mg penicillin) Framycetin Sulphate 100 mg (equivalent to 71.0 mg framycetin) EXCIPIENTS: For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Intramammary suspension. White to off white suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (at drying off) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For treatment of subclinical mastitis at drying off, and the prevention of new bacterial infections of the udder during the dry period in dairy cows, caused by bacteria susceptible to penicillin and framycetin. 4.3 CONTRAINDICATIONS Do not use in lactating cows. Do not use in case of hypersensitivity to the active substances or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Where there is a risk of summer mastitis, additional management procedures, such as fly control should be considered. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/12/2016_ _CRN 7023998_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Official and local antimicrobial policies should be taken in Прочитать полный документ